Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2010 Feb 5;5(2):e9067. doi: 10.1371/journal.pone.0009067

Prevalence and Risk Factors for Trachoma in Central and Southern Malawi

Khumbo Kalua 1,6,*, Tobias Chirwa 2, Linda Kalilani 3, Sam Abbenyi 4, Mavuto Mukaka 5, Robin Bailey 6
Editor: Jeremiah M Ngondi7
PMCID: PMC2816719  PMID: 20140094

Abstract

Background

Trachoma, one of the neglected tropical diseases is suspected to be endemic in Malawi. Objectives: To determine the prevalence of trachoma and associated risk factors in central and southern Malawi.

Methodology/Principal Findings

A population based survey conducted in randomly selected clusters in Chikwawa district (population 438,895), southern Malawi and Mchinji district (population 456,558), central Malawi. Children aged 1–9 years and adults aged 15 and above were assessed for clinical signs of trachoma. In total, 1010 households in Chikwawa and 1016 households in Mchinji districts were enumerated within 108 clusters (54 clusters in each district). A total of 6,792 persons were examined for ocular signs of trachoma. The prevalence of trachomatous inflammation, follicular (TF) among children aged 1–9 years was 13.6% (CI 11.6–15.6) in Chikwawa and 21.7% (CI 19.5–23.9) in Mchinji districts respectively. The prevalence of trachoma trichiasis (TT) in women and men aged 15 years and above was 0.6% (CI 0.2–0.9) in Chikwawa and 0.3% (CI 0.04–0.6) in Mchinji respectively. The presence of a dirty face was significantly associated with trachoma follicular (TF) in both Chikwawa and Mchinji districts (P<0.001).

Conclusion/Significance

Prevalence rates of trachoma follicles (TF) in Central and Southern Malawi exceeds the WHO guidelines for the intervention with mass antibiotic distribution (TF>10%), and warrants the trachoma SAFE control strategy to be undertaken in Chikwawa and Mchinji districts.

Introduction

Trachoma is an infectious disease that is caused by serotypes A, B, Ba and C of the bacterium Chlamydia trachomatis [1], [2]. Repeated infections can eventually lead to eyelids thickening and developing scars resulting in the eyelashes turning inwards and rubbing on the cornea [3], causing abrasions and ulceration, eventually leading to visual loss and blindness. The World Health Organization (WHO) has categorized the clinical features of trachoma in five stages using the WHO simplified grading system [4], [5] as follows; Trachomatous inflammation follicular (TF), Trachomatous inflammation intense (TI), Trachoma Scarring (TS), Trachomatous trichiasis (TT) and Corneal opacity (CO).

Trachoma is still considered a leading cause of preventable blindness in sub-Saharan Africa especially in countries that have poor environmental sanitation, inadequate water supply and poor socio-economic status [6], [7]. Worldwide, despite improvements in trachoma control over the recent years, there are still about 8.2 million people with trachoma trichiasis and an estimated 40.6 million cases of active disease [6], [8]. Blinding trachoma remains a problem where living conditions facilitate continuous transmission of Chlamydia trachomatis among family members [9]. Indeed trachoma is among the many neglected tropical diseases (NTD's) that are associated with poverty and produce a disease burden almost as great as that associated with human immunodeficiency virus/AIDS, tuberculosis, or malaria [10] and may be treated simultaneously with other diseases.

The strategy recommended for control of trachoma is known as SAFE, an acronym standing for Surgery for Trichiasis, Antibiotic for active disease, Facial cleanliness promotion to reduce transmission from person to person by flies and Environmental improvement which reduces transmission of the infection. The WHO aims to achieve Global Elimination of Blinding Trachoma by the year 2020 (GET2020) through implementation of the SAFE strategy [11]. Countries like Malawi in Sub-Saharan Africa which had some districts in the Southern region with high prevalence rates of trachoma (TF >30%) over 20 years ago [12] but did not implement the SAFE strategy are still listed as trachoma endemic countries by WHO despite the lack of recent epidemiological data about the current overall prevalence of blinding trachoma. Trachoma is suspected to be endemic in Malawi even though there has been few prevalence population based studies, the last one done in Chikwawa in 1999 [13]. A lack of district level prevalence data exists in many other countries suspected of having endemic trachoma [14]. However some evidence suggests that prevalence of trachoma can be reduced over a period of time even if only parts of the SAFE strategy, rather than the whole strategy has been implemented [13]. There is therefore a need to conduct population based studies of trachoma in areas where the prevalence was assessed previously and some trachoma control activities implemented afterwards; this is necessary to document the changes over a period of time and give guidance as to whether there is still a need to implement the recommended SAFE strategy in an integrated manner. The integration of trachoma control strategies with other neglected tropical diseases (NTD's) may be beneficial in Sub-Saharan Africa [15].

We sought to determine the prevalence of trachoma in one previously highly endemic district (Chikwawa) and in one other district (Mchinji) in Malawi suspected of having trachoma but with no previous prevalence data.

Methods

Ethical approval was obtained from the National Health Sciences Research Committee (NHSRC) based in Lilongwe, and the district health administrative offices (DHO) for Chikwawa and Mchinji Districts, in Malawi. Upon explanation of the purpose of the study, written informed consent was obtained from all subjects who participated in the study. Where the participant was a minor, written informed consent was obtained from the guardian.

The study districts were Chikwawa in the southern of Malawi, population 438,895 (National Statistical Office preliminary results, population and housing census, Zomba, Malawi 2008), known for high prevalence rates of trachoma [12], and Mchinji district in central region, population 456,558 and no trachoma survey done before.

Figure 1 shows map of Malawi and the districts where the study was done.

Figure 1. Map of Malawi showing survey sites.*.

Figure 1

*Mchinji in Central and Chikwawa in Southern Malawi.

The 1988 trachoma study in Chikwawa district reported by Tielsch et al. found prevalence rates of TS to be 40% in those aged above 50 years while the prevalence of inflammatory trachoma (TF/TI) in children aged 1–2 years was nearly 50%. Hoechsmann et al. (14), in a study done in the same district 13 years later reported prevalence rates of trachoma follicles (TF) in those aged 1–6 years as being 13.9%.

Both Chikwawa district and Mchinji have a referral general hospital where an Ophthalmic clinical officer is based and regularly conducts eye clinics at the district hospital and also conducts outreach eye clinics at various health centres located within the community. The clinical officer is trained to do trichiasis surgeries within the district hospital using the WHO recommended bilamelar tarsal plate rotation. However coverage for trichiasis surgery is very low in both districts with less than 50 cases done per year, and this has been mainly attributed to lack of surgical equipment. Health promotion on primary eye care including hygiene and environmental control is regularly done by community health workers (Health Surveillance assistants) who have been trained and are fully based in the community. Trachomatous infections are currently treated with tetracycline eye ointment within the health centers and at the district hospitals. Both district hospitals have a strong environmental department which focuses on safe water and other hygienic programmes as part of their health promotion activities.

The study was a cross-sectional household based survey designed to obtain district level prevalence estimates for trachoma; TF and TI (collectively constituting active trachoma) in children aged 1–9 years; trichiasis (TT) in adult men and women aged 15 years and above, and to assess the predisposing risk factors. The study was conducted between July and September 2008.

Sample Size

To calculate the sample size, the WHO recommended methodology for sample size calculation for trachoma surveys [16] was used. Using the following parameters: and an assumed prevalence of TF/TI of 20% for both districts, with the lowest expected rate being 16%, a significance level of 5%, [confidence of 95%], and a design effect of 4, the number of children aged 1–9 years and adults aged 15 years and above required for this study was 1728 children and 1414 adults per district and these were sampled concurrently. With an estimated average of 1.8 children per household in Malawi, and an assumed response rate of 90%, a total of 1054 households were needed in each district Accordingly 54 clusters (villages) per district were selected through probability proportionate to size sampling (PPS), using census data from the 1998 as the sampling frame, in which subsequently 20 households per cluster were sampled. A list was produced of the villages and their respective population sizes. A column was created with the cumulative population across the enumeration areas and the total population was divided by the number of clusters (54) required to derive the sampling interval. The first cluster was selected by multiplying the sampling interval with a random number between 0 and 1, the resulting number was traced in the cumulative population column, and the first cluster was taken from the corresponding village. Consecutive clusters were identified by adding the sampling interval to the previous number. The second stage of selecting 20 households within the cluster was done randomly, using a known list of all households within the cluster (collected by a community health worker) and a computer programme choosing 20 randomly selected households from the list.

Data Collection

For data collection, 8 teams of paired ophthalmic clinical officers underwent a one week certification training session conducted by an expert on grading and trachoma surveys (RB) and observed by a member from the International Trachoma initiative (SA). Prior to the training, a baseline exercise involving a set of 50 digital eyelid photographs (derived from studies in Gambia, Tanzania and Ethiopia) were shown to the trainees with grade explanations and advice on grading. After training, a further set of 50 slides were projected and shown to the trainees, and they were asked to grade as taught during the training. Differences among trainees were examined and all queries were resolved. Trainees then went to the field for a pilot study, where they were observed examining and grading children and adults. After the field exercise, trainees were assessed using a final set of 50 digital photographs that were projected and graded independently by the trainer. A final Kappa score was obtained by comparing the grades of each trainee with the trainer (RB). For certification all trainee examiners were required to reach a kappa value of 0.61–0.8 (i.e. having fewer than 5 disagreements among the fifty slides).

Data was collected using 3 generic WHO standard forms for trachoma survey (village, household and ocular examination questionnaires). On arrival in the field, the first questionnaire was administered to village headman, the second questionnaire to the head of the household and the third questionnaires to all members of household. The village level questions focused on health facilities within the village, sources of water that the villages used and whether they had committees to oversee water issues in the villages, and schools that could be used as sources of health promotion in the area.

Each eye was examined for presence of trachoma using a 2.5 × magnifying loupe (Binomag plastic, Zabby's, India). Other data collected included the environmental factors such as availability of functional latrines, presence of solid waste or animal pens, distance to water source and hygienic condition of children faces (clean/unclean). A clean face was defined as absence of obvious ocular and nasal discharge.

Information on the questionnaires was double entered into an electronic Microsoft Access version 2003 database at a central location, cleaned and imported into Stata 10 (Stata Corp, Texas USA) software which was used for analysis. Survey logistic regression was used in order to adjust for clustering in the household. All tests were tested at 5% significance level. Firstly, univariate survey logistic regression analysis was performed to assess whether each of the following variables: clean face, water availability, privacy, sex, toilet, human faces, presence of kraal, means of waste disposal, radio and bicycle were associated with trachoma follicular (TF) in children aged 1–9 years. Secondly, multivariate logistic regression analysis was performed to assess which variables were independently associated with the outcome (TF).

Results

A total of 1010 households in Chikwawa district and 1016 households in Mchinji district out of the planned 1054 households for each district were enumerated, giving an overall response rate of 96%. Overall a total of 6,792 persons (3,283 persons in Chikwawa and 3,509 persons in Mchinji) participated in ocular examination exercise. Among these 2,430 were children aged 1–9 years,1183 children aged 10–14 years and 3,179 were adults aged 15 and above.

Table 1 shows the baseline characteristics (sex and age range) of the study participants and Table 2 shows availability of household characteristics that were studied in the two districts. In regard to demographics of examined population in each cluster, overall there were 4.4 individuals per household (95% CI 4.31–4.57) in Chikwawa and 4.1 individuals per household (95% CI 3.95–4.20) in Mchinji respectively. As for children aged 1–9 years, there were 1.12 children per household in Chikwawa (95% CI 1.06–1.20) and 1.3 children per household in Mchinji (95% CI 1.21–1.34).

Table 1. Baseline characteristics of the study participants.

Variable Chikwawa district Mchinji district
No. (%) No. (%)
Sex
Male 1599(48.7) 1688(48.1)
Female 1684(51.3) 1821(51.9)
Age Group (years)
1–9 561(17) 622(18)
10–14 1587(52) 1592(45)
15+ 1135(35) 1295(37)
ALL 3283(100) 3509(100)

Table 2. Availability of household characteristics in Chikwawa and Mchinji districts.

Chikwawa Mchinji
No. (%) No. (%)
Type of Toilet
Pit Latrine 482(48.7) 629(62.2)
Flush Toilet 43(4.4) 2(0.2)
Other 6(0.6) 0 (0)
None 458(46.3) 380 (37.6)
Faeces around 15 m of the house
Yes 71 (7.1) 6 (0.6)
No 924 (92.9) 1009 (99.4)
Loose garbage around the house
Yes 446 (44.8) 166 (16.4)
No 549 (55.2) 849 (83.6)
Water source
Tap water 114 (11.4) 98 (9.7)
Rain Water Harvest 1 (0.1) 1 (0.1)
Protected Well 17 (1.7) 104 (10.3)
Unprotected Well 98 (9.8) 421 (41.7)
Borehole 570 (56.9) 356 (35.3)
Dam 1 (0.1) 0
River/Stream 200 (19.9) 30 (3.0)
Water all year round
Yes 734 (73.3) 762 (75.3)
No 267 (26.7) 250 (24.7)
Distance to main water source
<15 minutes 666 (66.3) 810 (80.0)
16–30 minutes 248 (24.7) 190 (18.7)
31–60 minutes 77 (7.7) 13 (1.3)
>60 minutes 14 (1.4) 0

The prevalence rates of trachoma follicular (TF) and trachoma intense (TI) in children aged 1–9 years and trachoma scarring (TS), trachoma trichiasis (TT) and cornea opacity (CO) in adults aged 15 years and above in Chikwawa and Mchinji respectively are shown in Table 3 The prevalence of TF among children aged 1–9 years was found to be 13.6% (95% CI 11.6–15.6) in Chikwawa and 21.7% (95% CI 19.5–23.9) in Mchinji districts respectively. Taking into account the fact that children aged 1–9 years constituted 37% of the total population in the two districts; this translates into a total of 22,085 children from Chikwawa and 36,657 from Mchinji with trachoma follicles that need mass antibiotic treatment.

Table 3. Prevalence rates for Trachoma* in Chikwawa and Mchinji districts.

District Children aged 1–9 years Adults aged 15 and above
TF TI TS TT CO
% CI** % CI % CI** % CI % CI
Chikwawa 13.6 11.6–15.6 2.0 1.1–2.8 6.0 3.5–7.5 0.6 0.2–0.9 0.6 0.1–1.1
Mchinji 21.7 19.5–23.9 3.4 2.2–4.4 4.8 3.5–5.1 0.3 0.04–0.6 0.2 0.8–4.7
*

Trachoma Follicles (TF), Trachoma Intense (TI), in children aged 1–9 years; Trachoma scarring (TS), Trachoma Trichiasis (TT) and Cornea Opacity (CO) in adults aged 15 years and above.

**

95% confidence Intervals.

The prevalence of trachoma follicles (TF) among children aged 1–9 years by age group is shown in table 4:

Table 4. Prevalence of Trachoma follicles (TF) by age in Chikwawa and Mchinji districts.

Chikwawa Mchinji
Age(years) Examined With TF (%) Examined With TF (%)
1 114 10(8.8) 145 22(15.2)
2 134 23(17.2) 191 51(26.7)
3 156 33(21.2) 171 44(25.7)
4 162 22(13.6) 172 46(26.7)
5 148 19(12.8) 163 42(25.8)
6 109 19(17.4) 123 20(16.3)
7 133 11(8.2) 109 24(22.0)
8 105 11(10.5) 145 25(17.2)
9 74 6(8.1) 76 7(9.2)
Total 1135 154(13.6) 1295 281(21.7)

Table 5 shows the prevalence of trachoma trichiasis (TT) by sex among adults aged 15 years and above in Chikwawa and Mchinji districts respectively. The prevalence of trachoma trichiasis (TT) was 0.6 (CI 0.2–0.9) in Chikwawa and 0.3 (CI 0.04–0.6) in Mchinji district respectively. There was no significant difference in prevalence rates for trichiasis between men and women in both districts. Taking into consideration that adults aged 15 and above contributed to 45% of total population in both districts, prevalence rates of trichiasis obtained translate to a total of 1580 and 616 cases of people with trichiasis needing surgery in Chikwawa and Mchinji districts respectively.

Table 5. Prevalence of Trachoma Trichiasis (TT) by sex in Chikwawa and Mchinji districts.

Chikwawa No examined No with TT % (*CI) P value
Males 613 1 0.2(−0.2,0.6) 0.17
Females 979 8 0.8(0.3,1.2)
Total 1592 9 0.6(0.2,0.9)
*

95% confidence Intervals.

Table 6 shows risk factors for trachoma follicular (TF) obtained through univariate and multivariate logistical regression after accounting for clustering in Chikwawa and Mchinji districts respectively. Risk factors for trachoma follicular (TF) obtained through univariate logistical regression after accounting for clustering in households in Mchinji were dirty face (OR 3.66, CI 2.20–6.09, P<0.001), presence of water throughout the year (OR 0.36,CI 0.17–0.75, P = 0.006), and no privacy to toilet (OR 3.29, CI 1.52–7.13,P = 0.003), while on multivariate analysis only dirty face (OR 6.54, CI 1.20–35.63, P = 0.046) and no privacy to toilet (OR 18.47, CI 2.1–160.1, P = 0.009) were significant. In Chikwawa, significant risk factors obtained on univariate logistical regression were dirty face (OR 1.94, CI 1.45–2.85, P<0.001), age (OR −0.06, CI −0.005,−0.12, P = 0.03) and being female (OR 0.65, CI 0.49–0.87, P = 0.004) but nothing was significant on multivariate regression.

Table 6. Risk factors for Trachoma follicular (TF) obtained through univariate and multivariate logistical regression.

Univariate analysis Multivariate analysis
Chikwawa
Variable No OR CI* P-value No OR CI* P-value
Age(1–9) 1122 −0.06 −0.12,−0.005 0.03 246 0.91 0.80,4.4 0.167
Sex (Female) 1122 0.65 0.49, 0.87 0.004 0.56 0.25,1.21 0.139
Presence of dirty face 1096 1.94 1.45, 2.85 <0.001 1.72 0.82,3.61 0.148
No radio in household 1043 1.31 0.91, 1.89 0.144
No bicycle in household 1043 0.49 0.57, 1.25 0.392
Surrounding area
Absence of toilet 1029 0.83 0.57, 1.21 0.328
Toilet with no privacy 538 1.08 0.58, 2.02 0.801
Presence of feces 1040 1.69 0.80, 3.58 0.172
Presence of Kraal 496 0.59 0.35, 1.00 0.052
Presence of garbage 1028 0.54 0.28, 1.04 0.067
Source of water 1042
Unprotected well 1.38 0.68, 2.82 0.368
Borehole 0.81 0.45, 1.45 0.476
River 0.56 0.28, 1.10 0.091
Mchinji 459
Age (years) −0.05 −0.14, 0.04 0.25
Sex (Female) 0.76 0.49, 1.19 0.49
Presence of dirty face 3.66 2.20, 6.09 <0.001 74 6.54 1.20,35.63 0.046
No radio 0.89 0.54, 1.49 0.67
No bicycle 0.89 0.54, 1.47 0.65
Surrounding area
Absence of toilet 379 0.98 0.58, 1.65 0.94
Toilet with no privacy 228 3.29 1.52, 7.13 0.003 74 18.47 2.1–160.1 0.009
Presence of Kraal 166 0.81 0.39, 1.70 0.58
Source of water 386
Unprotected well 0.63 0.27, 1.47 0.29
Borehole 0.78 0.33, 1.86 0.58
Water lasts all year 0.36 0.17, 0.75 0.006 74 0.74 0.28,1.96 0.55
*

95% confidence Interval.

In regard to sources of water, after accounting for clustering in the households, the main source of water for Mchinji was unprotected well (42%) and for Chikwawa it was borehole (57%) (Table 2). Health facilities (hospitals, health centres, and health posts) and schools were evenly distributed in Mchinji and Chikwawa districts with each cluster having access to services within a distance of 5–10 kilometres.

Discussion

This study was conducted to determine the prevalence of trachoma infections (TF/TI) among children aged 1–9 years, the prevalence of trachoma scaring (TS),trachoma trichiasis (TT) and cornea opacity (CO) among adult men and women aged 15 years and above and association with the risk factors for trachoma in Chikwawa and Mchinji districts. To our knowledge this is one of the largest and most recent trachoma population based Ophthalmological survey undertaken in Malawi (total persons examined was 6,792), the first large population based study of trachoma done in Malawi was conducted in Chikwawa more than 20 years ago [12]. However several other studies have reported the prevalence on trachoma in some areas of Malawi even though some were not specifically designed for trachoma [17], [18]. The results of this study show that trachoma follicular infections (TF) is still a disease of public health importance despite a marked reduction in prevalence in Chikwawa over a 20 year period (from 50% to 13.6%), and these results are in agreement with a relatively recent study by Hoechsmann et al.(14) who reported a prevalence of active trachoma in Chikwawa in children aged 1–6 years as 13.9%. One limitation of comparing the present study with the earlier ones is the difference is the age range of children examined, the current study using the WHO age range of children from 1–9 years versus 1–6 years in earlier studies.

The prevalence of trachoma follicular (TF) found among children aged 1–9 years in both districts exceeds the WHO guidelines for the intervention with mass antibiotic distribution (TF>10%), and warrants the SAFE strategy to be undertaken to address the issue of trachoma in Chikwawa and Mchinji districts.

The prevalence of trichiasis (TT) observed in adults aged 15 years and above in Chikwawa (0.6%) and Mchinji (0.3%) has overlapping confidence intervals indicating that the rates were not significantly different in the two districts. However the values are higher than WHO cut off point of threshold for elimination of trichiasis (TT) as a public health problem (0.1%) and indicate that surgical intervention for trichiasis should be implemented in the two districts.

Indeed the obtained prevalence rates of trichiasis translate to large numbers of people needing surgical intervention for trichiasis in Chikwawa and Mchinji districts (1580 and 616 respectively), and some of these may end up developing cornea opacity (CO) and becoming blind if not surgically corrected. It is important to note that not all cases of trachomatous trichiasis progress to cornea opacity, and that some of the cornea opacities seen in the community are not caused by trachoma; but may be caused by other cornea infections and concurrent use of traditional herbal medicines for treatment. However it is most likely that cases of cornea opacities seen in the two districts are as a result of complications of trachoma trichiasis, as the uptake and surgical coverage of trichiasis surgery in the two districts is very low. Findings from talking to ophthalmic staff and other health workers from the two hospitals in the districts indicated that only a few trichiasis surgeries were being done, and this was mostly due to lack of trichiasis surgical equipment in the hospitals.

In regards to risk factors, although lack of water and long distance to water source is associated with active trachoma (TF/TI) [9], [19], [20] it is apparent from findings of this study that long distance to a water source was not a major factor in the transmission of trachoma in both districts as more than 90% of population had access to a water source of a distance of less than 30 minutes of walking. This finding is in contrast to Hoechsmann et.al (13) ] who found that trachoma follicular was associated with a longer distance to the primary water source in the Chikwawa district. It should be noted however that since the Hoechsmann study, many boreholes were drilled in Chikwawa district resulting in most residents accessing water within a walking distance of 30 minutes. The hypothesis that reduction in trachoma follicular (TF) was related to environmental improvement in absence of antibiotic treatment is indeed supported by the readily availability of water and not the antibiotic. Currently both districts have access to only limited amounts of tetracycline eye ointment as an available drug and only use it for treating severe eye infections.

One limitation in interpreting the association of risk factors to active trachoma is that some of the factors studied (availability of water sources, pit latrines, garbage disposal and animal pens) were collected at household and village level, and may not be applicable to individual children. We do not still fully understand why particular individual children within the same environment and sometimes within same households are more prone to have active trachoma than others

The relatively lower rates of trachomatous infection found in Chikwawa compared with Mchinji coupled with findings that there was readily available water in Chikwawa than Mchinji may explain the decline of prevalence of trachoma in Chikwawa in absence of a trachoma control programme using the SAFE strategy. Chikwawa district has for many years been popularly known as the “home of trachoma in Malawi”, with previous prevalence estimates of TF nearly 50% in children aged 1–2 years [12]. Results from the present study suggests that the prevalence of TF has markedly declined despite not having trachoma SAFE strategy programmes in the area and this observation has also been noted by Hoechsmann and colleagues [13] who attributed the reduction of TF in absence of antibiotic mass distribution to be due to presence of water and hygiene programmes which were initiated in their study area.

There was a strong correlation on logistical regression between prevalence of trachoma follicles (TF) and presence of dirty face in children in both Chikwawa and Mchinji (P<0.001), and no privacy to toilet in Mchinji but there was no correlation between presence of TF and waste disposal, animal pens and presence or absence of toilet. However it has been noted that garbage disposal in the surrounding area and presence of cattle feces may be associated with presence of Musca sorbens, the flies that are responsible for the transmission of trachoma [21].

In summary, the prevalence of trachoma found in Chikwawa and Mchinji districts confirms that trachoma is still a disease of public health importance in the two districts and calls for implementation of the full SAFE strategy. It is important to note that certain activities of the SAFE strategy (antibiotic distribution) may be integrated with control of other diseases and some studies have reported success [22]. The Ministry of Health in Malawi is controlling Onchocerciasis, Schistomiasis and lymphatic filariasis (LF) through community-directed treatment with multi-drug therapy and has systems in place that would possibly allow extension of integrated neglected tropical diseases (NTDs) control to include the antibiotic component of the trachoma control. However this should only be done when plans for implementing other components of the SAFE strategy have been fully put in place.

There are many similarities in the distribution and disease pattern of trachoma observed in the two districts. Chikwawa is located in the Southern region (south west zone) and Mchinji is located in the Central Region (central east zone) of Malawi and it may be possible that the prevalence of trachoma may be similar in other districts located within the same regions. However findings from this study cannot be easily generalized to the rest of other districts in Malawi as the two districts were selected only from the two out of the three regions in Malawi. Therefore carefully designed national surveys to cover randomly selected districts suspected of having trachoma in all the three regions should be planned and conducted to generate prevalence data at national level.

Acknowledgments

We would like to acknowledge the contributions by the following individuals and organisations during the survey period: Ms Ruby Ng'ong'ola for the overall logistical support provided during the survey, the Ministry of Health task force for the Trachoma survey, Lions Sight First Eye hospital staff, District Health management teams for Chikwawa and Mchinji, Community Health Sciences unit in Lilongwe, Lions Aid Norway for facilitating transport in the field, all the data collection team members and the community health workers that took part in the survey.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: The study was funded through National Prevention of Blindness Committee, Ministry of Health, Malawi by Sight Savers International (SSI), a UK based charity organisation which has been supporting eye care activities in Malawi for the last 30 years. SSI Malawi country office staff helped in providing logistics for the survey (printing questionnaires and assisting with transportation) but did not take part in manuscript writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Mabey DC, Forsey T, Treharne JD. Serotypes of Chlamydia trachomatis in The Gambia. Lancet. 1987;2:452. doi: 10.1016/s0140-6736(87)90984-6. [DOI] [PubMed] [Google Scholar]
  • 2.Bailey R. rRNA-based tests for chlamydial infection in trachoma. Br J Ophthalmol. 2007;91:271. doi: 10.1136/bjo.2006.105270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bowman RJ, Jatta B, Cham B, Bailey RL, Faal H, et al. Natural history of trachomatous scarring in The Gambia: results of a 12-year longitudinal follow-up. Ophthalmology. 2001;108:2219–2224. doi: 10.1016/s0161-6420(01)00645-5. [DOI] [PubMed] [Google Scholar]
  • 4.WHO. WHO simplified trachoma grading system. Community Eye Health Dec. 2004;17(52):68. [PMC free article] [PubMed] [Google Scholar]
  • 5.Thylefors B, Dawson CR, JR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bulletin of World Health Organisation. 1987;65:477–483. [PMC free article] [PubMed] [Google Scholar]
  • 6.Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol. 2009;93:563–568. doi: 10.1136/bjo.2008.148494. [DOI] [PubMed] [Google Scholar]
  • 7.Burton MJ. Trachoma: an overview. Br Med Bull. 2007;84:99–116. doi: 10.1093/bmb/ldm034. [DOI] [PubMed] [Google Scholar]
  • 8.Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844–851. [PMC free article] [PubMed] [Google Scholar]
  • 9.West SK, Munoz B, Lynch M, Kayongoya A, Mmbaga BB, et al. Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. Am J Epidemiol. 1996;143:73–78. doi: 10.1093/oxfordjournals.aje.a008659. [DOI] [PubMed] [Google Scholar]
  • 10.Reddy M, Gill SS, Kalkar SR, Wu W, Anderson PJ, et al. Oral drug therapy for multiple neglected tropical diseases: a systematic review. Jama. 2007;298:1911–1924. doi: 10.1001/jama.298.16.1911. [DOI] [PubMed] [Google Scholar]
  • 11.Mariotti SP, Pararajasegaram R, Resnikoff S. Trachoma: looking forward to Global Elimination of Trachoma by 2020 (GET 2020). Am J Trop Med Hyg. 2003;69:33–35. doi: 10.4269/ajtmh.2003.69.5_suppl_1.0690033. [DOI] [PubMed] [Google Scholar]
  • 12.Tielsch JM, West KP, Katz J, Keyvan-Larijani E, Tizazu T, et al. The epidemiology of trachoma in southern Malawi. Am J Trop Med Hyg. 1988;38:393–399. doi: 10.4269/ajtmh.1988.38.393. [DOI] [PubMed] [Google Scholar]
  • 13.Hoechsmann A, Metcalfe N, Kanjaloti S, Godia H, Mtambo O, et al. Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi. Ophthalmic Epidemiol. 2001;8:145–153. doi: 10.1076/opep.8.2.145.4169. [DOI] [PubMed] [Google Scholar]
  • 14.Polack S, Brooker S, Kuper H, Mariotti S, Mabey D, et al. Mapping the global distribution of trachoma. Bull World Health Organ. 2005;83:913–919. [PMC free article] [PubMed] [Google Scholar]
  • 15.Brady MA, Hooper PJ, Ottesen EA. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol. 2006;22:285–291. doi: 10.1016/j.pt.2006.05.007. [DOI] [PubMed] [Google Scholar]
  • 16.WHO. Trachoma Control: A guide for programme managers.Published jointly by the World Health Organization, the London School of Hygiene and Tropical Medicine, and the International Trachoma Initiative. Geneva. WHO Library Cataloguing-in-Publication Data. 2006.
  • 17.Myatt M, Limburg H, Minassian D, Katyola D. Field trial of applicability of lot quality assurance sampling survey method for rapid assessment of prevalence of active trachoma. Bull World Health Organ. 2003;81:877–885. [PMC free article] [PubMed] [Google Scholar]
  • 18.Courtright P, Hoechsmann A, Metcalfe N, Chirambo M, Noertjojo K, et al. Changes in blindness prevalence over 16 years in Malawi: reduced prevalence but increased numbers of blind. Br J Ophthalmol. 2003;87:1079–1082. doi: 10.1136/bjo.87.9.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Baggaley RF, Solomon AW, Kuper H, Polack S, Massae PA, et al. Distance to water source and altitude in relation to active trachoma in Rombo district, Tanzania. Trop Med Int Health. 2006;11:220–227. doi: 10.1111/j.1365-3156.2005.01553.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ngondi J, Matthews F, Reacher M, Onsarigo A, Matende I, et al. Prevalence of risk factors and severity of active trachoma in southern Sudan: an ordinal analysis. Am J Trop Med Hyg. 2007;2007 Jul;77(1):126–32 77: 126–132. [PubMed] [Google Scholar]
  • 21.Emerson PM, Lindsay SW, Alexander N, Bah M, Dibba SM, et al. Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet. 2004;363:1093–1098. doi: 10.1016/S0140-6736(04)15891-1. [DOI] [PubMed] [Google Scholar]
  • 22.Emerson PM, Ngondi J, Biru E, Graves PM, Ejigsemahu Y, et al. Integrating an NTD with One of “The Big Three”: Combined Malaria and Trachoma Survey in Amhara Region of Ethiopia. PLoS Negl Trop Dis. 2008;2:e197. doi: 10.1371/journal.pntd.0000197. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES